Rajani Kanth Vangala,
Director of Research
Dr. Rajani Kanth Vangala, finished his Ph.D in Human Biology specializing on Hematolo-oncology from Department of Medicine III, Ludwig Maximillians University, Munich, Germany followed by post doctoral research at Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden working on developing Karolinska-Institutet microarray chip and novel computational algorithms for microarray data analysis. After his post doctoral work, he joined Department of Hematology, Imperial College London, UK as senior researcher and worked on stem cell therapy models and DNA repair mechanisms in acute and chronic myeloid leukemias. He was also awarded the technology entrepreneur fellowship for business management studies by Tanaka Business School, Imperial College London. Further to this experience, he started a company named Innovo Biologicals Pvt. Ltd. focusing on molecular diagnostics and sold it to venture capital company and joined Institute of Bioinformatics and Applied Biotechnology, Bangalore as faculty before moving to Thrombosis Research Institute (TRI), Bangalore. He is presently the Director of Research and his work focuses on identification of biomarkers for translation to drug development and clinical utility using integrative translational informatics, genomics, proteomics and nanotechnology
|
|
|
